Skip to main content

Guttmacher Institute

Donate Now

Highlights

  • COVID-19 impact
  • IPSRH: Focus on Abortion
  • Adding It Up
  • Guttmacher-Lancet Commission
  • U.S. policy resources
  • State policy resources
  • State legislation tracker

Reports

  • Global
  • U.S.

Articles

  • Global research
  • U.S. research
  • Policy analysis
  • Guttmacher Policy Review
  • Op-eds & external blogs

Fact Sheets

  • Global
  • U.S.
  • U.S. State Laws and Policies

Data & Visualizations

  • Data center
  • Infographics

Peer-Reviewed Journals

  • International Perspectives on Sexual and Reproductive Health
  • Perspectives on Sexual and Reproductive Health

Global

  • Abortion
  • Contraception
  • HIV & STIs
  • Pregnancy
  • Teens

U.S.

  • Abortion
  • Contraception
  • HIV & STIs
  • Pregnancy
  • Teens

Our Work By Geography

  • Global
  • Asia
  • Latin America & the Caribbean
  • Sub-Saharan Africa
  • United States

Who We Are

  • About us
  • Staff
  • Board
  • Job opportunities
  • History
  • Contact

Media

  • Media office
  • News releases

Support Our Work

  • Make a gift today
  • Monthly Giving Circle
  • Guttmacher Guardians
  • Donate stock or securites
  • Guttmacher Legacy Circle
  • Financials
  • Annual Report

Awards and Scholarships

  • Darroch Award
  • Richards Scholarship

Search form

Good reproductive health policy starts with credible research

 

Connect With Us

  • Facebook
  • Instagram
  • Twitter
  • Email
Guttmacher Institute

Good reproductive health policy starts with credible research

 

Donate Now

Connect With Us

  • Facebook
  • Instagram
  • Twitter
  • Email

Highlights

  • COVID-19 impact
  • IPSRH: Focus on Abortion
  • Adding It Up
  • Guttmacher-Lancet Commission
  • U.S. policy resources
  • State policy resources
  • State legislation tracker

Reports

  • Global
  • U.S.

Articles

  • Global research
  • U.S. research
  • Policy analysis
  • Guttmacher Policy Review
  • Op-eds & external blogs

Fact Sheets

  • Global
  • U.S.
  • U.S. State Laws and Policies

Data & Visualizations

  • Data center
  • Infographics

Peer-Reviewed Journals

  • International Perspectives on Sexual and Reproductive Health
  • Perspectives on Sexual and Reproductive Health

Global

  • Abortion
  • Contraception
  • HIV & STIs
  • Pregnancy
  • Teens

U.S.

  • Abortion
  • Contraception
  • HIV & STIs
  • Pregnancy
  • Teens

Our Work By Geography

  • Global
  • Asia
  • Latin America & the Caribbean
  • Sub-Saharan Africa
  • United States

Who We Are

  • About us
  • Staff
  • Board
  • Job opportunities
  • History
  • Contact

Media

  • Media office
  • News releases

Support Our Work

  • Make a gift today
  • Monthly Giving Circle
  • Guttmacher Guardians
  • Donate stock or securites
  • Guttmacher Legacy Circle
  • Financials
  • Annual Report

Awards and Scholarships

  • Darroch Award
  • Richards Scholarship

Search form

Global

HIV & STIs

The Guttmacher Institute’s international work on HIV and other STIs focuses on developing regions. Our research and advocacy efforts have focused on the linkages between HIV and sexual and reproductive health and rights, the impact of STIs on maternal and newborn health, the need for new technologies (including multipurpose prevention technologies) and U.S. support for global AIDS programs. 

  • Fact Sheet

    Investing in Sexual and Reproductive Health in Low- and Middle-Income Countries

  • Policy Analysis

    The COVID-19 Outbreak: Potential Fallout for Sexual and Reproductive Health and Rights

  • Policy Analysis

    Just $10 Per Person a Year Could Provide Sexual and Reproductive Health Services to All—Will the United States Help Make That Happen?

Top Facts & Statistics

  • 6.6M

    women in developing regions have an unmet need for antiretroviral therapy
  • 1.5M

    women living with HIV become pregnant each year worldwide
  • $10.60

    the annual per-person cost in LMICs to meet the need for essential sexual and reproductive health services

Resources

  • December 2020 Fact Sheet

    Investir dans la santé sexuelle et reproductive en Afrique australe

    Global

    • Abortion
    • Contraception
    • HIV & STIs
    • Pregnancy
    • Teens
  • November 2020 Fact Sheet

    Investing in Sexual and Reproductive Health in Eastern Asia

    Global

    • Abortion
    • Contraception
    • HIV & STIs
    • Teens
  • November 2020 Fact Sheet

    Investing in Sexual and Reproductive Health in Asia

    Global

    • Abortion
    • Contraception
    • HIV & STIs
    • Pregnancy
    • Teens
  • November 2020 Fact Sheet

    Investing in Sexual and Reproductive Health in Southeast Asia

    Global

    • Abortion
    • Contraception
    • HIV & STIs
    • Teens
  • November 2020 Fact Sheet

    Investing in Sexual and Reproductive Health in Western Asia

    Global

    • Abortion
    • Contraception
    • HIV & STIs
    • Teens
  • November 2020 Fact Sheet

    Investing in Sexual and Reproductive Health in Central Asia

    Global

    • Abortion
    • Contraception
    • HIV & STIs
    • Teens
  • November 2020 Fact Sheet

    Investing in Sexual and Reproductive Health in Southern Asia

    Global

    • Abortion
    • Contraception
    • HIV & STIs
    • Teens
  • November 2020 Fact Sheet

    Investing in the Sexual and Reproductive Health of Women in India

    Global

    • Abortion
    • Contraception
    • HIV & STIs
    • Pregnancy
    • Teens
  • July 2020 Fact Sheet

    Invertir en salud sexual y reproductiva en países de ingreso bajo y mediano

    Global

    • Abortion
    • Contraception
    • HIV & STIs
    • Pregnancy
    • Teens
  • July 2020 News Release

    Provision of Essential Sexual and Reproductive Health Care Would Reduce Unintended Pregnancies, Unsafe Abortions and Maternal Deaths by About Two-Thirds

    Global

    • Abortion
    • Contraception
    • HIV & STIs
    • Pregnancy
    • Teens

Pages

  • « first
  • ‹ previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • next ›
  • last »
Explore the Data Center

Hear From An Expert

Supporting and adequately funding the development of multipurpose prevention technologies (MPTs) should be a higher priority for the U.S. government, especially at a time when private sector support is missing. Unfortunately, current funding—while critical in advancing this important work to date—has not been sufficient. This inadequate funding may significantly hamper the timely development of MPTs that could be a huge boost to achieving U.S. global health priorities

Heather D. Boonstra

Vice President for Public Policy

View sexual and reproductive health research and analysis in your location

THE TIME IS NOW

Stand up for sexual and reproductive health and rights.
We need your support.

Donate
Guttmacher Institute
Reproductive rights are under attack. Will you help us fight back with facts?
Donate Now
Follow Guttmacher:

Connect With Us

  • Facebook
  • Instagram
  • Twitter
  • YouTube
  • LinkedIn

Footer Menu

  • Privacy Policy
© 2021 Guttmacher Institute. The Guttmacher Institute is registered as a 501(c)(3) nonprofit organization under the tax identification number 13-2890727. Contributions are tax deductible to the fullest extent allowable.

Get Our Updates